ScreenCell® logo
Contact
Quote

Archives

2024

  • Lung cancer
  • Rosie A Harris, Elizabeth A Stokes, Tim J P Batchelor, Eveline Internullo, Doug West, Simon Jordan, Andrew G Nicholson, Ian Paul, Charlotte Jacobs, Michael Shackcloth, Sarah Feeney, Vladimir Anikin, Niall McGonigle, Richard Steyn, Maninder Kalkat, Dionisios Stavroulias, May Havinden Williams, Syed Qadri, Karen Dobbs, Vipin Zamvar, Lucy Macdonald, Surinder Kaur, Chris A Rogers, Eric Lim; VIOLET trialists

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial
  • Short format

Is ScreenCell’s technology sensitive enough to detect small amounts of Circulating Tumor Cells ?
  • Short format

Can we perform mutational studies on CTCs enriched by ScreenCell technology?
  • Company

ScreenCell joins the European Liquid Biopsy Society (ELBS)
  • Breast cancer
  • Fei Ye, Janine Wechsler, Amira Bouzidi, Georges Uzan, Sina Naserian

Fast and efficient isolation of murine circulating tumor cells using screencell technology for pre-clinical analyzes
  • Lung cancer
  • Maxim B Freidin, Andee Tay, Dasha V Freydina, Dimple Chudasama, Andrew G Nicholson, Alexandra Rice, Vladimir Anikin, Eric Lim

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer
  • Short format

What role will the analysis of Circulating Tumor Cells (CTCs) play in 2024 ?
  • Glioblastoma
  • Hannah R Barber, Claire M Perks, Kathreena M Kurian

Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

Follow ScreenCell on

Subscribe